Publication | Closed Access

Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain

Mu ReceptorIntraperitoneal InjectionFunctional SelectivityPain MedicineMedicineMolecular PainNeuropeptide ReceptorNeuropharmacologyExperimental PharmacologyPharmacotherapyNeuroscienceNervous SystemPharmacologyRat BrainNeuropeptidesPain Research